Updates are available Correction dated 2021-01-05
Click to view Correction: https://doi.org/10.1038/s41577-020-00497-5
-
Authors
Pollard, Andrew J. http://orcid.org/0000-0001-7361-719X
Bijker, Else M.
- License Information
-
More Information
Article History
Accepted: 19 November 2020
First Online: 22 December 2020
Change Date: 5 January 2021
Change Type: Correction
Change Details: A Correction to this paper has been published: https://doi.org/10.1038/s41577-020-00497-5.
Competing interests
: A.J.P. is Chair of the UK Department of Health and Social Care’s (DHSC) Joint Committee on Vaccination and Immunisation (JCVI), a member of the World Health Organization (WHO) Strategic Advisory Group of Experts on Immunization (SAGE) and a National Institute for Health Research (NIHR) Senior Investigator. The views expressed in this article do not necessarily represent the views of the DHSC, JCVI, NIHR or WHO. E.M.B. declares no competing interests. Oxford University has entered into a partnership with AstraZeneca for the development of a viral vectored coronavirus vaccine.
Free to read: This content has been made available to all.
